Paul D Loprinzi1, Hyo Lee, Bradley J Cardinal. 1. Department of Exercise Science, Donna and Allan Lansing School of Nursing and Health Sciences, Bellarmine University, Louisville, KY 40205, USA. ploprinzi@bellarmine.edu
Abstract
PURPOSE: We have a limited understanding of the objectively determined physical activity levels of cancer survivors at the population level. Further, we have even less of an understanding of this behavior by weight status (i.e., normal weight, overweight, and obese). Therefore, the purpose of this study was to describe accelerometer-assessed physical activity levels among US cancer survivors and to do so across weight status. METHODS: Data from the 2003-2006 NHANES was used. One hundred twenty-six adult cancer survivors wore an accelerometer for ≥4 days, with weight status determined from measured body mass index. RESULTS: Approximately 13 % of cancer survivors were sufficiently active (i.e., met current physical activity guidelines). Results were not significant for light-intensity physical activity; however, results showed that obese cancer survivors engaged in 47 % less MVPA than normal weight cancer survivors (rate ratio = 0.53; 95 % CI, 0.29-0.93). CONCLUSION: Most adult cancer survivors are insufficiently active and obese cancer survivors engage in less MVPA than their counterparts. IMPLICATIONS FOR CANCER SURVIVORS: Health care professionals are encouraged to increase cancer survivors' awareness of the minimum levels of MVPA needed for optimal health, particularly among obese cancer survivors. Additionally, cancer survivors should also be informed of the positive health outcomes associated with light-intensity physical activity.
PURPOSE: We have a limited understanding of the objectively determined physical activity levels of cancer survivors at the population level. Further, we have even less of an understanding of this behavior by weight status (i.e., normal weight, overweight, and obese). Therefore, the purpose of this study was to describe accelerometer-assessed physical activity levels among US cancer survivors and to do so across weight status. METHODS: Data from the 2003-2006 NHANES was used. One hundred twenty-six adult cancer survivors wore an accelerometer for ≥4 days, with weight status determined from measured body mass index. RESULTS: Approximately 13 % of cancer survivors were sufficiently active (i.e., met current physical activity guidelines). Results were not significant for light-intensity physical activity; however, results showed that obese cancer survivors engaged in 47 % less MVPA than normal weight cancer survivors (rate ratio = 0.53; 95 % CI, 0.29-0.93). CONCLUSION: Most adult cancer survivors are insufficiently active and obese cancer survivors engage in less MVPA than their counterparts. IMPLICATIONS FOR CANCER SURVIVORS: Health care professionals are encouraged to increase cancer survivors' awareness of the minimum levels of MVPA needed for optimal health, particularly among obese cancer survivors. Additionally, cancer survivors should also be informed of the positive health outcomes associated with light-intensity physical activity.
Authors: C Charlier; E Pauwels; L Lechner; H Spittaels; J Bourgois; I DE Bourdeaudhuij; E VAN Hoof Journal: Eur J Cancer Care (Engl) Date: 2012-05-17 Impact factor: 2.520
Authors: Jae Youn Chung; Dong Hoon Lee; Ji-Hye Park; Mi Kyung Lee; Dong-Woo Kang; Jihee Min; Dong-Il Kim; Duck Hyoun Jeong; Nam Kyu Kim; Jeffrey A Meyerhardt; Lee W Jones; Justin Y Jeon Journal: Support Care Cancer Date: 2013-01-06 Impact factor: 3.603
Authors: Richard P Troiano; David Berrigan; Kevin W Dodd; Louise C Mâsse; Timothy Tilert; Margaret McDowell Journal: Med Sci Sports Exerc Date: 2008-01 Impact factor: 5.411
Authors: Laurien M Buffart; Melissa S Y Thong; Goof Schep; Mai J M Chinapaw; Johannes Brug; Lonneke V van de Poll-Franse Journal: PLoS One Date: 2012-05-02 Impact factor: 3.240
Authors: Maria Pisu; Wendy Demark-Wahnefried; Kelly M Kenzik; Robert A Oster; Chee Paul Lin; Sharon Manne; Ronald Alvarez; Michelle Y Martin Journal: J Cancer Surviv Date: 2017-01-09 Impact factor: 4.442
Authors: Amal A Wanigatunga; Gillian K Gresham; Pei-Lun Kuo; Pablo Martinez-Amezcua; Vadim Zipunnikov; Sydney M Dy; Eleanor M Simonsick; Luigi Ferrucci; Jennifer A Schrack Journal: Cancer Date: 2018-10-01 Impact factor: 6.860
Authors: Xiaochen Zhang; Ashley F Haggerty; Justin C Brown; Robert Giuntoli; Lilie Lin; Fiona Simpkins; Lorraine T Dean; Emily Ko; Mark A Morgan; Kathryn H Schmitz Journal: Gynecol Oncol Date: 2015-08-22 Impact factor: 5.482